Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Patients were randomized to microwave ablation plus camrelizumab group or camrelizumab group.
Epistemonikos ID: a261bf7ff3e454c1e44f71d24d4105e7fa91408a
First added on: May 22, 2024